Education

5 Ways to Improve the Customer Experience for Oncologists

5 Ways to Improve the Customer Experience for Oncologists

One critical aspect of oncology drugmakers' business remains firmly rooted in the past. That's customer experience.

Five things for pharma marketers to know: Wednesday, August 10, 2016

Five things for pharma marketers to know: Wednesday, August 10, 2016

A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion

Finding a Better Strategy for Pricing Drugs

Finding a Better Strategy for Pricing Drugs

We need to consider that not every expenditure is beneficial to patients: perhaps that Super Bowl commercial or that sales meeting in Maui may not be in their best interest.

ACCME, PharmedOut spar over CME money

ACCME, PharmedOut spar over CME money

The main accreditation body for CME activities traded barbs with an academic critic over courses designed to enlighten doctors about hypoactive sexual desire disorder.

Exploring the Opportunity For Halal In Healthcare

Exploring the Opportunity For Halal In Healthcare

There is an immediate need for greater education regarding halal and vaccines for Muslim consumers worldwide.

Five things for pharma marketers to know: Tuesday, July 21

Five things for pharma marketers to know: Tuesday, July 21

Physicians criticize pricing of Orkambi, Vertex's new cystic-fibrosis drug; the EU approves Amgen's PCSK9 inhibitor Repatha; PhRMA boosts lobbying spending in the second quarter

CMS updates CME guidance

CMS updates CME guidance

New rules will require manufacturers to report some indirect payments made to physicians for CME activities.

Private equity firm acquires CME provider

Vesey Street Capital Partners acquired Atlanta-based CME provider Imedex.

21st Century Cures, Amarin Court Case Advance

21st Century Cures, Amarin Court Case Advance

Pharma's efforts to evolve restrictions about off-label marketing move forward.

House expected to vote on 21st Century Cures

House expected to vote on 21st Century Cures

The legislation would allow drugmakers to share information about their products beyond what is included on the FDA-approved label.